Potential Markers in Cardiac Hypertrophy?

@inproceedings{Malinowski2012PotentialMI,
  title={Potential Markers in Cardiac Hypertrophy?},
  author={Bartosz Malinowski and Gabriele Fulgheri and Michal Wicinski and Elżbieta Grześk and Grażyna Odrowąż-Sypniewska and Grzegorz Grześk and Nasser Darwish},
  booktitle={EJIFCC},
  year={2012}
}
Cardiomyopathies are diagnosed based on medical history of patient (symptoms and family history), physical examination, results of echocardiogram and in some situations additionally ECG or chest-X-ray results. Currently used non-invasive diagnostic methods, could be complemented by biochemical tests. In this review some emerging potential biomarkers such as: osteopontin, ST-2 receptor, osteoprotegerin, neopterin, urocortins, growth differentiation factor 15 and urotensin II are described. In… CONTINUE READING

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 53 references

Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.

Journal of the American College of Cardiology • 2004
View 3 Excerpts
Highly Influenced

Role of IL-33 in inflammation and disease

Journal of Inflammation • 2011
View 1 Excerpt

Prognostic value of osteoprotegerin in chronic heart failure: The GISSI‐HF trial

R Roysland, S Masson, Omland, V Milani
American Heart Journal • 2010
View 2 Excerpts

Similar Papers

Loading similar papers…